Related references
Note: Only part of the references are listed.
Article
Immunology
Jonathan M. Cohen et al.
Summary: Little is known about the risk of multisystem inflammatory syndrome in children (MIS-C) with different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In southeast England, MIS-C rates per confirmed SARS-CoV-2 infections in children aged 0-16 years were 56% lower during prevaccine Delta, 66% lower during postvaccine Delta, and 95% lower during the Omicron period.
CLINICAL INFECTIOUS DISEASES
(2023)
Article
Clinical Neurology
Alexander Grundmann et al.
Summary: The objective of this study was to assess the impact of treatment with dexamethasone, remdesivir, or both on neurological complications in acute COVID-19. The study found that treatment with dexamethasone, remdesivir, or both was associated with a lower frequency of neurological complications in hospitalized COVID-19 patients, with the greatest benefit observed in patients who received both drugs together.
ANNALS OF NEUROLOGY
(2023)
Article
Geriatrics & Gerontology
Atul Anand et al.
Summary: This study used the 4AT test to analyze the relationships between delirium and 30-day mortality, length of stay, and home time. The results showed that the 4AT scores were strongly linked with mortality, length of stay, and home time. These findings highlight the need for a better understanding of why delirium is associated with poor outcomes and the importance of improving delirium detection and treatment.
Article
Clinical Neurology
Alessandro Pezzini et al.
Summary: The study aimed to characterize acute ischemic stroke patients with SARS-CoV-2 infection and evaluate the prediction performance of clinical and laboratory parameters for in-hospital outcomes. Patients with COVID-19 had distinct risk factors, increased stroke severity, and higher in-hospital mortality rate compared to non-COVID-19 patients. A simple model based on clinical and routine laboratory parameters showed high accuracy in identifying ischemic stroke patients with SARS-CoV-2 infection with poor prognosis.
JOURNAL OF NEUROLOGY
(2022)
Article
Clinical Neurology
Simone Beretta et al.
Summary: This study investigated the phenotype of stroke patients with and without COVID-19 infection and their impact on in-hospital mortality. The study found that COVID+ stroke patients required more respiratory support and had a higher in-hospital mortality rate. Symptomatic interstitial pneumonia was identified as the major driver of mortality in COVID+ stroke patients.
NEUROLOGICAL SCIENCES
(2022)
Article
Multidisciplinary Sciences
Bhagteshwar Singh et al.
Summary: This study investigated the spectrum of neurological disease in hospitalized COVID-19 patients and analyzed the clinical outcomes and factors associated with poor outcomes. The study found that encephalopathy and cerebrovascular events were the most common diagnoses, with cerebrovascular event patients more likely to have poor outcomes. Specific risk factors for poor outcomes included breathlessness on admission and elevated D-dimer. Overall, neurological COVID-19 disease poses a considerable burden in terms of disease outcomes and use of hospital resources.
Article
Psychiatry
Maxime Taquet et al.
Summary: COVID-19 is associated with increased risks of neurological and psychiatric sequelae. The duration of these risks, their impact on children and adults, and the differences in risk profiles among SARS-CoV-2 variants remain unclear. A 2-year retrospective cohort study analyzed data from electronic health records of COVID-19 patients and found that the risk trajectories differed based on age and outcome. While the risk of mood and anxiety disorders returned to baseline after 1-2 months, the risks of cognitive deficit, dementia, psychotic disorders, and epilepsy or seizures remained increased at the end of the 2-year follow-up period. Children had a more benign overall profile of psychiatric risk but sustained higher risk for certain diagnoses. The findings highlight the importance of understanding the individual and population-level risks of neurological and psychiatric disorders after SARS-CoV-2 infection.
Article
Immunology
Andrea Pilotto et al.
Summary: SARS-CoV-2 infection is associated with a wide spectrum of encephalitis characterized by different clinical presentations, response to treatment, and outcomes. The study identified subtypes of encephalitis based on MRI results, with patients showing acute demyelinating encephalomyelitis and limbic encephalitis having a delayed onset and more severe COVID-19 respiratory involvement. Patients with MRI alterations exhibited worse response to treatment and final outcomes.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Neurosciences
Roberta Ferrucci et al.
Summary: Cognitive abnormalities were frequently found in COVID-19 patients 5 months after hospital discharge, with some experiencing deficits in processing speed and verbal memory. Bivariate analysis indicated a positive correlation between factors like arterial oxygen partial pressure, fractional inspired oxygen ratio, and SpO2 levels during hospitalization, and verbal memory performance.
Article
Medicine, General & Internal
Sherry H. -Y. Chou et al.
Summary: This study included patients with clinically diagnosed or laboratory-confirmed COVID-19 at 28 centers across 13 countries and 4 continents from March 1 to September 30, 2020. Neurological manifestations were prevalent among hospitalized patients with COVID-19 and were associated with higher in-hospital mortality. Patients with preexisting neurological disorders were at increased risk of developing neurological signs and/or syndromes in COVID-19.
Review
Clinical Neurology
Erin F. Balcom et al.
Summary: COVID-19 is a global pandemic caused by SARS-CoV-2 infection, leading to acute and chronic disorders affecting the nervous system. Acute neurological symptoms include stroke, seizures, and cognitive dysfunction, while chronic neurological sequelae such as exercise intolerance and pain are reported. Various studies suggest potential mechanisms of viral neuroinvasion, but further research is needed to understand the underlying pathogenic processes.
Article
Psychiatry
Maxime Taquet et al.
Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.
Editorial Material
Critical Care Medicine
Arjen J. C. Slooter et al.
INTENSIVE CARE MEDICINE
(2020)
Article
Clinical Neurology
Ling Mao et al.
Article
Clinical Neurology
Carlo Ferrarese et al.
NEUROLOGICAL SCIENCES
(2020)
Editorial Material
Clinical Neurology
Mark Ellul et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
(2020)
Review
Clinical Neurology
Mark A. Ellul et al.
Article
Clinical Neurology
Alessandro Pezzini et al.
NATURE REVIEWS NEUROLOGY
(2020)
